1) FCM-DNA ploidy analysis
FCM-DNA倍体分析
1.
Besides routine cytology examination, FCM-DNA ploidy analysis and CEA were detected.
目的应用FCM-DNA倍体分析和CEA测定来探讨其对良恶性胸腹水的鉴别诊断价值。
2) DNA ploidy analysis
DNA倍体分析
1.
Clinicopathological significance of c-kit expression and DNA ploidy analysis in renal cell carcinomas;
肾细胞癌中c-kit蛋白表达和DNA倍体分析的临床病理学意义
2.
The clinical value of associated pre-operation screening by TCT and DNA ploidy analysis for patients with benign uterine diseases;
TCT和DNA倍体分析在子宫良性疾病术前检查中的临床价值
3.
The value of DNA ploidy analysis in ascites connecting with CA125 in serum to diagnose ovarian cancer
腹水DNA倍体分析联合血清CA125检测在卵巢癌诊断中的价值
3) DNA analysis
DNA倍体分析
1.
Comparison of the diagnostic value of DNA analysis and CEA and SF level in benign and malignant pleural effusions;
DNA倍体分析、癌胚抗原、铁蛋白对良恶性胸腔积液诊断价值的研究
2.
Objective:To investigate the diagnostic value of DNA analysis with flow cytometry in malignant pleural effusions and evaluate the diagnostic value and clinical feasibility of DNA analysis combined the CEA and SF detection in malignant pleural effusions.
目的:探讨流式细胞仪DNA倍体分析对恶性胸腔积液的诊断价值,并同癌胚抗原、铁蛋白的检测方法相比较,以评估三种方法联合检测恶性胸腔积液的诊断价值和临床可行性。
3.
Objective:To investigate the diagnostic value of DNA analysis with flow cytometry in malignant pleuroperitoneal and evaluate the diagnostic value and clinical feasibility of DNA analysis combined the CEA,Ft and CA19-9 detection in malignant pleuroperitoneal fluid.
目的:探讨流式细胞仪DNA倍体分析对恶性胸腹水的诊断价值,并同癌胚抗原、铁蛋白和糖类抗原19-9的检测方法相比较,以评估四种方法联合检测恶性胸腹水的诊断价值和临床可行性。
4) DNA content analysis
DNA倍体分析
1.
Objective: To study the significance of DNA content analysis by flow cytometry in pathologic assessment of otolaryngocarcinoma.
目的:了解流式细胞术DNA倍体分析在耳鼻咽喉-头颈外科肿瘤辅助诊断中的价值。
5) DNA-analysis/Ploidies
DNA分析/倍体
补充资料：DNA分子花窗(沿B―DNA轴线方向看)
[图]
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条